Article
Expression of CD44 variants and its association with survival in pancreatic cancer.
Japanese journal of cancer research : Gann - 1 Oct 1998
Gotoda T, Matsumura Y, Kondo H, Saitoh D, Shimada Y, Kosuge T, Kanai Y, Kakizoe T
Abstract excerpt
Since the CD44 variant 6(v6) molecule has been noted as a marker for tumor metastasis and prognosis in several tumors, we examined whether or not v6 is a useful marker for evaluating the prognosis of pancreatic cancer patients. In addition, we attempted to assess the clinicopathological implications for pancreatic cancer of the variant 2 (v2) isoform using a recently developed monoclonal antibody against a v2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
